Q1 2024 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day and welcome to the Q1 FY '24 Earnings Conference Call of Eris Lifesciences Limited.
We have with us on the call today Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you. And over to you, sir.
Thank you. Good afternoon, and welcome to our conference call for the first quarter of FY '24. Our branded formulations business accounts for 97% of our consolidated revenue, and this includes the standalone entity, Eris Lifesciences, it includes Oaknet Healthcare, our insulin business, Eris MJ, Eris Therapeutics, which houses our Gujarat facility commercialized in March and Aprica. This segment excludes EHPL.
The operating revenue for our branded formulations
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
